Author

Pedro Berraondo

Instituto de Salud Carlos IIIORCID 0000-0001-7410-1865Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Agavni MesropianiD· 1 shared Albert Gris‐OliveriD· 1 shared Alexis I. CocozakiiD· 1 shared Amaya López-PascualiD· 1 shared Ana Hernández de SandeiD· 1 shared Antonio Pineda‐LucenaiD· 1 shared Borja Castelló-UribeiD· 1 shared Bruno SangroiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Agavni MesropianORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyCell Reports MedicinePeer-reviewedMar 31, 2026

Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma

Elena Adán-Villaescusa, Borja Castelló-Uribe, Iker Uriarte…·Maite G Fernandez-Barrena

This study shows that inhibiting G9a enhances the effectiveness of immune checkpoint inhibitors in hepatocellular carcinoma by improving tumor immunogenicity and T cell infiltration.

3 citationstop 2%

mousebulk RNA-seq

𝕏 PostBluesky